Introduction to E-Science

An introduction to computationally-enabled science, challenges, and opportunities.

Data Management Policies and Issues with Life Science Data

Data management and sharing are relatively new concepts in the health and life sciences fields. This presentation will cover some basic policies as well as the impediments to data sharing unique to health and life sciences data.

Overview of Data Management Planning Tools

These Data Management Plans are more comprehensive and complex than in the past. Libraries around the nation are trying to put together tools to help researchers write plans that conform to the new requirements. This session will look at some of these tools.

Compliance: E-Science Mandates and Policies

Data collected under federally funded research is subject to compliance rules and regulations. Policies affecting what you can and cannot do with your data, who is responsible, and what role your institution plays can vary with funding agencies and the type of data collected. This talk will address many of the compliance issues associated with research data, as well as funder mandates that you need to be aware of to ensure compliance.

April 25, 2012

Geneva Henry, Executive Director of the Center for Digital Scholarship, Rice University. Data rights and ownership of digital research data can impact how you use data, how others use data you've collected, and how rights are determined in collaborative research. Copyright rules governing data vary from one country to the next, making data ownership in international collaborations particularly murky. Licensing the use of data sets from the start is one way to address these issues early and provide a means for easily sharing datasets that can be cited and properly attributed. This talk with introduce issues associated with digital research data governance and how to protect your rights with data you work with.

La escasez impuesta : el software libre y el status económico de los bienes inmateriales

Ante el despliegue de posibilidades para crear, reproducir y compartir contenidos que la informática proporciona, surgieron incesantes debates sobre su estatuto económico. Las leyes de propiedad intelectual promulgan medidas cada vez más restrictivas para consumidores y productores, lo que erige barreras a la cultura y favorece monopolios sobredimensionados. Frente a esta situación emergen voces disidentes como el movimiento del software libre. En este artículo, haremos un análisis del debate de los bienes inmateriales, el papel de las leyes de propiedad intelectual y las reivindicaciones del los partidarios del software libre.

Construcción de repositorios institucionales open source con Software Greenstone

Se aborda la construcción de repositorios institucionales open source con Software Greenstone. Se realiza un recorrido teórico y otro modélico desarrollando en él una aplicación práctica. El primer recorrido, que constituye el marco teórico, comprende una descripción, de: la filosofía open access (acceso abierto) y open source (código abierto) para la creación de repositorios institucionales. También abarca en líneas generales las temáticas relacionadas al protocolo OAI, el marco legal en lo que hace a la propiedad intelectual, las licencias y una aproximación a los metadatos. En el mismo recorrido se abordan aspectos teóricos de los repositorios institucionales: acepciones, beneficios, tipos, componentes intervinientes, herramientas open source para la creación de repositorios, descripción de las herramientas y finalmente, la descripción ampliada del Software Greenstone; elegido para el desarrollo modélico del repositorio institucional colocado en un demostrativo digital. El segundo recorrido, correspondiente al desarrollo modélico, incluye por un lado el modelo en sí del repositorio con el Software Greenstone; detallándose aquí uno a uno los componentes que lo conforman. Es el insumo teórico-práctico para el diseño -paso a paso- del repositorio institucional. Por otro lado, se incluye el resultado de la modelización, es decir el repositorio creado, el cual es exportado en entorno web a un soporte digital para su visibilización. El diseño del repositorio, paso a paso, constituye el núcleo sustantivo de aportes de este trabajo de tesina

Construcción de repositorios institucionales open source con Software Greenstone

Se aborda la construcción de repositorios institucionales open source con Software Greenstone. Se realiza un recorrido teórico y otro modélico desarrollando en él una aplicación práctica. El primer recorrido, que constituye el marco teórico, comprende una descripción, de: la filosofía open access (acceso abierto) y open source (código abierto) para la creación de repositorios institucionales. También abarca en líneas generales las temáticas relacionadas al protocolo OAI, el marco legal en lo que hace a la propiedad intelectual, las licencias y una aproximación a los metadatos. En el mismo recorrido se abordan aspectos teóricos de los repositorios institucionales: acepciones, beneficios, tipos, componentes intervinientes, herramientas open source para la creación de repositorios, descripción de las herramientas y finalmente, la descripción ampliada del Software Greenstone; elegido para el desarrollo modélico del repositorio institucional colocado en un demostrativo digital. El segundo recorrido, correspondiente al desarrollo modélico, incluye por un lado el modelo en sí del repositorio con el Software Greenstone; detallándose aquí uno a uno los componentes que lo conforman. Es el insumo teórico-práctico para el diseño -paso a paso- del repositorio institucional. Por otro lado, se incluye el resultado de la modelización, es decir el repositorio creado, el cual es exportado en entorno web a un soporte digital para su visibilización. El diseño del repositorio, paso a paso, constituye el núcleo sustantivo de aportes de este trabajo de tesina

Indian Patent Policy and Publich Health : implications from the Japanese Experience

The introduction of pharmaceutical product patents in India and other developing countries is expected to have a significant effect on public health and local pharmaceutical industries. This paper draws implications from the historical experience of Japan when it introduced product patents in 1976. In Japan, narrow patents and promotion of cross-licensing were effective tools to keep drug prices in check while ensuring the introduction of new drugs. While the global pharmaceutical market surrounding India today differs considerably from that of the 1970's, the Japanese experience offers a policy option that may profitably be considered by India today. The Indian patent system emphasizes the patentability requirement in contrast to the Japanese patent policy which relied on narrow patents and extensive licensing. R&D by local firms and the development of local products may be promoted more effectively under the Japanese model.

Who Develops Innovations in Medicine for the Poor? Trends in Patent Applications Related to Medicines for HIV/AIDS, Tuberculosis, Malaria and Neglected Diseases

Who invents medicines for the poor of the world? This question becomes very important where the WTO allows low income countries to be unbound by the TRIPS agreement. This agreement concerns medicines for infectious diseases such as HIV/AIDS, tuberculosis and malaria. These diseases cause serious damage to low income countries. Under these circumstances, some scholars wonder if anyone will continue innovative activities related to treating these diseases. This paper sought to answer this question by collecting and analyzing patent data of medicines and vaccines for diseases using the database of the Japan Patent Office. Results indicate that private firms have led in innovation not only for global diseases such as HIV/AIDS but also diseases such as malaria that are spreading exclusively in low income countries. Innovation for the three infectious diseases is diverse among firms, and frequent patent applications by high-performing pharmaceutical firms appear prominent even after R&D expenditure, economies of scale, and economies of scope are taken into account.

Patent policy and public health in developing countries: lessons from Japan

The introduction of pharmaceutical product patents in India and other developing countries is expected to have a significant effect on public health and local pharmaceutical industries. This paper draws implications from the historical experience of Japan when it introduced product patents in 1976. In Japan, narrow patents and promotion of cross-licensing were effective tools to keep drug prices in check while ensuring the introduction of new drugs. While the global pharmaceutical market surrounding India today differs considerably from that of the 1970's, the Japanese experience offers a policy option that may profitably be considered by India today. The Indian patent system emphasizes the patentability requirement in contrast to the Japanese patent policy which relied on narrow patents and extensive licensing. R&D by local firms and the development of local products may be promoted more effectively under the Japanese model.